In the present study, the frequencies of both CD4+ and CD8+ TCM were significantly lower in ESCC patients treated with CRT compared to the frequency in patients treated with CT (Figure 2a), and NLR was significantly higher in CRT group than CT group (Supplementary Figure S4). The gene discussed is CD4; the disease is esophageal squamous cell carcinoma.